Aseptika Limited began developing Activ8rlives in 2010 and is currently developing its third generation of integrated systems, which can be used by consumers and their healthcare service providers using a wide range of platforms or devices to better enable effective and easy self-monitoring. Incorporating sensors and monitors ranging from consumer accessories to in vitro diagnostics (IVDs), the systems currently focus on respiratory and cardiovascular disease, diabetes, cancer, promoting physical activity and weight management.
Aseptika Quality Management System
The Activ8rlives suite of self-care solutions are manufactured in-house or distributed under a strict quality management system. In 2018 we achieved certification to ISO 13485:2016 under Certificate Number MD691414 with the British Standards Institution (BSI) as our Notified Body.
This is a major milestone in the development of Aseptika as its certification covers the development and certification (CE-marking) of our own medical devices, medically-certified Apps and UK-based Cloud data management system.
Aseptika Information Governance
Aseptika works to the NHS Data Security & Protection Toolkit and Cyber Essentials Plus to provide services to the NHS, councils and individuals.